Clinical Pharmacokinetics of Daclatasvir/Sofosbuvir in Adolescents With Hepatitis C Virus

NCT03540212 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Chronic HCV Infection

Interventions

DRUG: Daclatasvir and sofosbuvir

Sponsor

Ain Shams University